London-based consumer healthcare group Haleon Plc (NYSE:HLN) stock is trading lower on Thursday. Haleon, GSK Plc’s (NYSE:GSK) spun off, reported revenue of 11.23 billion pounds (US$14.19 billion) for ...

The share sale and buyback are expected to reduce Pfizer's interest in Haleon from 32% to approximately 24%. In its fourth-quarter release, Haleon added that it expects to allocate £500 million to buy ...

(Reuters) -Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer will sell down its stake in the company to about 24%. Pfizer, which currently holds a 32% stake in Haleon, said ...

Citing a “weak U.S. consumer and retail environment, particularly in the more discretionary and seasonal categories,” British-based OTC marketer Haleon lowered its full-year guidance as it announced ...

Adds details from the report in paragraphs 3-4, background in paragraph 2 July 13 (Reuters) - Haleon HLN.L, the world's biggest standalone consumer health business, is planning to cut hundreds of ...

A GSK spinoff that has its U.S. headquarters in Warren, Haleon boasts several well-known brands, including anti-inflammatory drug Advil, Centrum multivitamin, Sensodyne toothpaste, Theraflu cold & flu ...

(Reuters) -Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil ...

Shares down 1% on slight decline in H1 adj operating margin Co raises annual organic revenue growth outlook to 7-8% Expects 9-11% growth in FY adj operating profit Aug 2 (Reuters) - Haleon raised its ...

March 18 (Reuters) - Consumer healthcare firm Haleon (HLN.L), opens new tab said on Monday that U.S. drugmaker Pfizer (PFE.N), opens new tab, its top shareholder, will sell down its stake in the ...

March 18 (Reuters) - Consumer healthcare giant Haleon HLN.L said on Monday that Pfizer PFE.N will sell about 630 million of its shares in the company, reducing the US drugmaker's stake to about 24%.